Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram vs venlafaxine vs buspirone for irritable bowel syndrome
IRCT20150630022991N10Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of escitalopram, venlafaxine and buspirone in irritable bowel syndrome (IBS) (3 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Irritable bowel syndrome symptoms and Patient quality of life. Started Dec 2017; status: completed.
02
Drugs
escitalopramvenlafaxinebuspirone
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on IRCT20150630022991N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150630022991N10.